传染性法氏囊病疫苗市场规模、份额和成长分析：按疫苗类型、给药途径、最终用户、地区和产业预测，2026-2033年

2024年全球传染性法氏囊病疫苗市值为2.9亿美元，预计将从2025年的3.1349亿美元成长到2033年的5.8456亿美元。预测期（2026-2033年）的复合年增长率预计为8.1%。

全球传染性法氏囊病疫苗市场的主要驱动力是家禽生产的成长和全球化。这主要是由于养殖密度增加和国际贸易导致疾病传播风险上升和经济脆弱性加剧。市场正在满足对抗高传染性病毒感染疾病的疫苗需求，这些病毒感染会威胁幼鸡的免疫力并造成重大生产损失。随着生产者将生物安全和家禽群健康放在首位，对重组疫苗和载体疫苗等技术先进的疫苗製剂的需求日益增长。分子诊断技术的创新能够早期检测变异株，而人工智慧 (AI) 透过整合供应链数据和即时资讯来增强需求预测。家禽一体化公司和生物技术公司之间的监管协调与合作正在为客製化疫苗解决方案铺平道路，并进一步扩大市场机会。

全球传染性法氏囊病疫苗市场驱动因素

随着家禽养殖业的快速扩张，养殖规模和密集程度日益提高，全球传染性法氏囊病疫苗市场也随之成长。这种情况增加了疫情爆发的风险，促使养殖户和综合家禽企业采取疫苗接种策略。由于生产者将动物健康放在首位，以提高生产力和产品质量，对有效疫苗的需求不断增长，迫使生产商扩大供应并创新客製化疫苗配方。不断增长的生产需求与预防性健康措施之间的这种协同作用，不仅使疫苗接种成为一种标准的农业实践，而且还推动了对分销网络和教育倡议的投资，从而促进了市场扩张。

全球传染性法氏囊病疫苗市场的限制因素

由于储存和处理要求必须严格控制温度，全球传染性法氏囊病疫苗市场面临许多限制因素。这些要求使分销变得复杂，尤其是在偏远和资源匮乏地区，加剧了物流挑战。对可靠低温运输基础设施的依赖给供应商带来了沉重的营运负担，可能因担心便利性和产品劣化风险而阻碍小规模生产者进行疫苗接种。这些分销障碍限制了地域覆盖范围，使供应链管理复杂化，并使得製造商难以在不进行大量运输和储存解决方案投资的情况下，确保疫苗在各种农业系统中的一致部署，从而阻碍了市场成长。

全球传染性法氏囊病疫苗市场趋势

全球传染性法氏囊病（法氏囊病）疫苗市场正经历着向重组技术和新型疫苗平台的显着转变，这些技术和平台正成为产业创新的核心。製造商之所以关注这些先进技术，是因为它们具有更高的安全性、可自订的免疫反应和高效的生产流程。这些平台能够开发抗原特异性製剂，并有助于与疾病监测策略相结合，使其在应对病毒株不断演变带来的挑战方面更具灵活性。因此，市场对既能相容于现代生产实践又能确保对不同家禽群体具有稳定疗效的疫苗的需求日益增长，这促使企业加大对可扩展生产系统的投资，并加强生物技术公司和动物用药品公司之间的合作。

目录

介绍

• 调查目的
• 市场定义和范围

调查方法

• 研究过程
• 二级资料和一级资料的方法
• 市场规模估算方法

执行摘要

• 全球市场展望
• 市场主要亮点
• 细分市场概览
• 竞争环境概述

市场动态及展望

• 总体经济指标
• 促进者和机会
• 抑制因素和挑战
• 供给面趋势
• 需求面趋势
• 波特的分析和影响

市场考察

• 关键成功因素
• 影响市场的因素
• 主要投资机会
• 生态系测绘
• 2025年市场吸引力指数
• PESTEL 分析
• 监理情势
• 价值链分析

全球传染性法氏囊病疫苗市场规模：依疫苗类型和复合年增长率划分（2026-2033 年）

• 减毒活病毒疫苗
  • 单股
  • 多价
• 灭活疫苗
  • 油腻的
  • 水溶性

全球传染性法氏囊病疫苗市场规模：依给药途径及复合年增长率划分（2026-2033 年）

• 注射药物
  • 肌肉内注射
  • 皮下注射
• 口服
  • 液体
  • 片剂配方

全球传染性法氏囊病疫苗市场规模：依最终用户和复合年增长率划分（2026-2033 年）

• 家禽养殖场
  • 商业农场
  • 小规模家禽养殖场
• 研究机构
  • 兽医医学调查
  • 农业调查
• 其他的

全球传染性法氏囊病疫苗市场规模：按地区和复合年增长率划分（2026-2033 年）

• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场公司采取的策略
• 近期市场趋势
• 企业市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 按细分市场进行企业市占率分析
  • 2023-2025年营收年比比较

主要企业简介

• Zoetis
• Merck Animal Health
• Boehringer Ingelheim
• Elanco
• Cegelec
• Hipra
• Intervet
• Vetoquinol
• Virbac
• Dechra Pharmaceuticals
• Neovia
• Bioveta
• Axiota Animal Health
• Biopharma
• HyGentec
• Liaoning Hile Biotechnology
• Jinsha River Holdings
• Chengdu Tiantai Technology
• Indivior
• Sihuan Pharmaceutical

结论与建议

Global Infectious Bursal Disease Vaccine Market size was valued at USD 290.0 Million in 2024 and is poised to grow from USD 313.49 Million in 2025 to USD 584.56 Million by 2033, growing at a CAGR of 8.1% during the forecast period (2026-2033).

The global Infectious Bursal Disease Vaccine market is primarily driven by the growth and globalization of poultry production, which heightens risks of disease transmission and economic vulnerability due to increased flock density and international trade. This market caters to the need for vaccines that combat a highly contagious viral infection that threatens the immune competence of young chickens, leading to significant production losses. As producers prioritize biosecurity and flock health, there is a growing preference for technologically advanced vaccine formulations, such as recombinant and vectored products. Innovations in molecular diagnostics enable early detection of variant strains, while AI enhances demand forecasting by integrating supply chain data and real-time insights. Regulatory alignment and collaborations between poultry integrators and biotech firms further open avenues for tailored vaccine solutions and expanded market opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Infectious Bursal Disease Vaccine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Infectious Bursal Disease Vaccine Market Segments Analysis

Global infectious bursal disease vaccine market is segmented by vaccine type, administration route, end user and region. Based on vaccine type, the market is segmented into Live Attenuated Vaccine and Inactivated Vaccine. Based on administration route, the market is segmented into Injectable and Oral. Based on end user, the market is segmented into Poultry Farms, Research Institutions and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Infectious Bursal Disease Vaccine Market

The global market for Infectious Bursal Disease vaccines is driven by the rapid growth of poultry production, which leads to larger and more intensive flocks. This situation heightens the risk of outbreaks, prompting farmers and poultry integrators to increasingly adopt vaccination strategies. As producers emphasize animal health to enhance both productivity and product quality, the demand for effective immunization rises, urging manufacturers to broaden their supply and innovate customized vaccine formulations. This synergy between increasing production demands and preventive health measures not only solidifies vaccination as a standard farming practice but also promotes investments in distribution networks and educational initiatives, thereby bolstering market expansion.

Restraints in the Global Infectious Bursal Disease Vaccine Market

The Global Infectious Bursal Disease Vaccine market faces significant limitations due to the necessity for strict temperature-controlled storage and handling. This requirement complicates distribution, particularly in remote or resource-limited areas, and increases logistical challenges. The reliance on a reliable cold chain infrastructure places greater operational demands on suppliers, potentially discouraging smallholder producers from implementing vaccination practices due to concerns about convenience and the risk of product spoilage. These distribution barriers hinder market growth by restricting geographic access, complicating supply chain management, and making it difficult for manufacturers to ensure consistent adoption across various farming systems without considerable investments in transportation and storage solutions.

Market Trends of the Global Infectious Bursal Disease Vaccine Market

The Global Infectious Bursal Disease Vaccine market is experiencing a notable shift towards recombinant and novel vaccine platforms, which are becoming central to industry innovation. Manufacturers are focusing on these advanced technologies due to their enhanced safety profiles, customized immune responses, and efficient production workflows. These platforms enable the development of antigen-specific formulations and facilitate integration with disease surveillance strategies, making them increasingly versatile in addressing the evolving challenges posed by viral strains. Consequently, there's a rising investment in scalable manufacturing systems and collaborations between biotech and animal health companies, driven by the growing demand for vaccines that ensure consistent efficacy across diverse poultry populations while aligning with modern production practices.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Value Chain Analysis

Global Infectious Bursal Disease Vaccine Market Size by Vaccine Type & CAGR (2026-2033)

• Market Overview
• Live Attenuated Vaccine
  • Single Strain
  • Multivalent
• Inactivated Vaccine
  • Oil-based
  • Water-based

Global Infectious Bursal Disease Vaccine Market Size by Administration Route & CAGR (2026-2033)

• Market Overview
• Injectable
  • Intramuscular
  • Subcutaneous
• Oral
  • Liquid Formulation
  • Tablet Formulation

Global Infectious Bursal Disease Vaccine Market Size by End User & CAGR (2026-2033)

• Market Overview
• Poultry Farms
  • Commercial Farms
  • Backyard Farms
• Research Institutions
  • Veterinary Research
  • Agricultural Research
• Others

Global Infectious Bursal Disease Vaccine Market Size & CAGR (2026-2033)

• North America (Vaccine Type, Administration Route, End User)
  • US
  • Canada
• Europe (Vaccine Type, Administration Route, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Vaccine Type, Administration Route, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Vaccine Type, Administration Route, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Vaccine Type, Administration Route, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Zoetis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cegelec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hipra
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intervet
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dechra Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neovia
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioveta
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Axiota Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biopharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HyGentec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Liaoning Hile Biotechnology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jinsha River Holdings
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chengdu Tiantai Technology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indivior
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sihuan Pharmaceutical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations